Merit Medical Launches SafeGuard Focus Cool™ Compression Device
August 08 2022 - 8:25AM
Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global
manufacturer and marketer of healthcare technology, today announced
the launch of its SafeGuard Focus Cool™ Compression Device, an
innovative addition to its SafeGuard® platform. It is part of a
broader cardiac portfolio that offers products and accessories
necessary for cardiac rhythm management, electrophysiology, and
lead extraction procedures as well as interventional cardiac
resynchronization therapy.
The new compression device builds upon the original SafeGuard
Focus™, a revolutionary idea that provides compression over closed
surgical sites which can assist hemostasis in patients with
pacemaker and implantable cardioverter defibrillator (ICD) pockets.
The SafeGuard Focus Cool offers the same high performance but with
an easy-to-prepare cooling solution that does not require
refrigeration, making it ideal for the lab environment.
More than 1 million cardiac pacemakers are implanted every year
worldwide, with 200,000 implanted in the United States alone.1 In
addition, more than 200,000 ICDs are implanted each year globally.2
As the older population continues to grow and these devices receive
expanding applications, the patient need for these therapies is
also expected to increase.1,2
“Access site complications, including swelling, discomfort,
bleeding, and infections, are things that concern
physicians after pacemaker and ICD implants. They may
impact the patient experience, create clinical risk, and prolong
hospitalization. Physicians are looking for solutions
to improve post-implant care,” said Dr. Grant Simons,
Chief of Heart Rhythm Services at Englewood Health NJ. “In my
practice, I’ve already seen the advantages of SafeGuard Focus in
providing controlled compression with a simple,
convenient device. We see adding a cooling feature
to the device as an advantage for our patients." Dr. Grant
Simons and his team were the first globally to use the SafeGuard
Focus Cool compression device on patients. Procedures were
performed with excellent outcomes despite uninterrupted
anticoagulation.
Learn more about the SafeGuard Focus Cool.
“Our ongoing collaboration with physicians allows us to
understand their specific clinical needs,” said Fred P.
Lampropoulos, Merit Medical’s Chairman and CEO. “The SafeGuard
Focus Cool is the result of Merit’s fundamental drive to react
quickly to these needs, innovating and delivering solutions that
advance patient care.”
ABOUT MERIT MEDICAL Founded in 1987, Merit Medical Systems,
Inc. is engaged in the development, manufacture, and distribution
of proprietary disposable medical devices used in interventional,
diagnostic, and therapeutic procedures, particularly in cardiology,
radiology, oncology, critical care, and endoscopy. Merit serves
client hospitals worldwide with a domestic and international sales
force and clinical support team totaling in excess of 600
individuals. Merit employs approximately 6,500 people
worldwide.
TRADEMARKS Unless noted otherwise, trademarks and
registered trademarks used in this release are the property of
Merit Medical Systems, Inc. and its subsidiaries in the United
States and other jurisdictions.
CONTACTSPR/Media InquiriesSarah Comstock Merit
Medical+1-801-432-2864 | sarah.comstock@merit.com
INVESTOR INQUIRIESMike Piccinino, CFA, IRC Westwicke -
ICR +1-443-213-0509 | mike.piccinino@westwicke.com
REFERENCES
- Bhatia N & El-Chami M. 2018. “Leadless Pacemakers: A
Contemporary Review.” J Geriatr Cardiol 15, no. 4 (Apr): 249 ̶ 253.
PMID 29915613.
- Ammannaya G. 2020. “Implantable Cardioverter Defibrillators—the
Past, Present and Future.” Arch Med Sci Atheroscler Dis. 5: e163 ̶
e170. PMID: 32832716.
Merit Medical Systems (NASDAQ:MMSI)
Historical Stock Chart
From Jun 2024 to Jul 2024
Merit Medical Systems (NASDAQ:MMSI)
Historical Stock Chart
From Jul 2023 to Jul 2024